These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9363034)

  • 1. Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study.
    Nijpels G; Popp-Snijders C; Kostense PJ; Bouter LM; Heine RJ
    J Clin Epidemiol; 1997 Sep; 50(9):1003-9. PubMed ID: 9363034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.
    Nijpels G; Popp-Snijders C; Kostense PJ; Bouter LM; Heine RJ
    Diabetologia; 1996 Jan; 39(1):113-8. PubMed ID: 8720611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma glucose concentration 60 min post oral glucose load and risk of type 2 diabetes and cardiovascular disease: Pathophysiological implications.
    Abbasi F; Tern PJ; Reaven GM
    Diab Vasc Dis Res; 2019 Jul; 16(4):337-343. PubMed ID: 30755013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus.
    Nijpels G
    Eur J Clin Invest; 1998 Sep; 28 Suppl 2():8-13. PubMed ID: 9777321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors.
    Heine RJ; Nijpels G; Mooy JM
    Diabet Med; 1996; 13(3 Suppl 2):S12-4. PubMed ID: 8689855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study.
    Ohmura T; Ueda K; Kiyohara Y; Kato I; Iwamoto H; Nakayama K; Nomiyama K; Ohmori S; Yoshitake T; Shinkawa A
    Diabetologia; 1994 Sep; 37(9):897-904. PubMed ID: 7806019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.
    Meigs JB; Nathan DM; Wilson PW; Cupples LA; Singer DE
    Ann Intern Med; 1998 Apr; 128(7):524-33. PubMed ID: 9518396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.
    de Vegt F; Dekker JM; Jager A; Hienkens E; Kostense PJ; Stehouwer CD; Nijpels G; Bouter LM; Heine RJ
    JAMA; 2001 Apr; 285(16):2109-13. PubMed ID: 11311100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of an acute insulin response predicts onset of type 2 diabetes in a Caucasian population with impaired glucose tolerance.
    Nijpels G; Boorsma W; Dekker JM; Hoeksema F; Kostense PJ; Bouter LM; Heine RJ
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2633-8. PubMed ID: 18460558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.
    Haffner SM; Gonzalez C; Mykkänen L; Stern M
    Diabetologia; 1997 Jul; 40(7):830-7. PubMed ID: 9243105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
    Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I
    Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance.
    Bardini G; Dicembrini I; Pala L; Cresci B; Rotella CM
    Diabet Med; 2011 Oct; 28(10):1229-33. PubMed ID: 21923697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin levels and the natural history of glucose intolerance in Nauruans.
    Dowse GK; Zimmet PZ; Collins VR
    Diabetes; 1996 Oct; 45(10):1367-72. PubMed ID: 8826973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults.
    McPhillips JB; Barrett-Connor E; Wingard DL
    Am J Epidemiol; 1990 Mar; 131(3):443-53. PubMed ID: 2301354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men.
    Eriksson KF; Lindgärde F
    Diabetologia; 1996 May; 39(5):573-9. PubMed ID: 8739917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.
    Meigs JB; Mittleman MA; Nathan DM; Tofler GH; Singer DE; Murphy-Sheehy PM; Lipinska I; D'Agostino RB; Wilson PW
    JAMA; 2000 Jan; 283(2):221-8. PubMed ID: 10634338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study.
    Alssema M; Dekker JM; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ;
    Diabetes Care; 2005 Apr; 28(4):860-5. PubMed ID: 15793186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.